Study

Plasma transforming growth factor-beta1 level and efficacy of alpha-tocopherol in patients with non-alcoholic steatohepatitis: a pilot study. – Cost Effective Supplements

Plasma transforming growth factor-beta1 level and efficacy of alpha-tocopherol in patients with non-alcoholic steatohepatitis: a pilot study.

Quick navigation


http://www.ncbi.nlm.nih.gov/pubmed/11564008


Conclusion of this study

Our data suggest that the measurement of the level of plasma transforming growth factor-beta1 represents a possible method of distinguishing between non-alcoholic steatohepatitis and non-alcoholic fatty liver. Long-term alpha-tocopherol treatment may be safe and effective for non-alcoholic steatohepatitis. A randomized, controlled, double-blind trial is needed to confirm the full potential of alpha-tocopherol in the management of non-alcoholic steatohepatitis.


Supplements analyzed in this study

Vitamin E

Health conditions analyzed in this study

Fatty Liver Disease


Slightly Positive
Vitamin E

Liver Damage


Slightly Positive
Vitamin E


Functions related to this study

Detox


Moderately Positive
Vitamin E

Overall health


Slightly Positive
Vitamin E


Body systems related to this study


Digestive System
Scroll to top